Efficacy and safety of acnecutan for acne treatment

Abstract

Acnecutan represents an innovative form of isotretinoin, having bioavailability The aim of our study was to evaluate safety and clinical efficacy of the drug isotretinoin (Acnecutan) in the treatment of patients with acne of medium-severe and severe. The treatment of 56 patients with acne, until the exchange rate dose of 100-120 mg/kg. The clinical results of the drug Acnecutan indicate a high level of safety and tolerability

References

  1. Leyden J. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003; 49: 200-10.
  2. Zaenglein A. Thiboutot D. Expert Committee Recommendations for Acne Management. Pediatrics. 2006; 118: 1188-99.
  3. Эллинг Д. Секреты дерматологии. СПб. 1999: 513.
  4. Самцов А.В. Акне и акнеформные дерматозы. М. 2009: 32-45.
  5. Rodondi N. et al. High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann Intern Med 2002; 136(8): 582-9.
  6. Zouboulis C.C. Exploration of retinoid activity and the role of inflammation in acne: issues affecting future directions for acne therapy. J Eur Acad Dermatol Venereol 2001; 15 (3): 63-7.
  7. Oshsendorf F., Degitz К. Drug therapy of acne. J Hautarzt 2008; 59(7): 579-89.

Copyright (c) 2011 SAMTsOV A.V., STATsENKO A.V., GORBUNOV Y.G., VOLKOVA S.V., KhAYRUTDINOV V.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies